Tue, Jan 24, 2023
On the NSE, the stock fell 1.93 per cent to Rs 1,349.05 apiece.
More >
Tue, Nov 01, 2022
According to Street, Gland Pharma reported a weak set of results in Q2FY23 with consolidated revenue declining by 3.3 per cent year-on-year (YoY) due to weak performance in geographies.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
